Interferon alfa is a conservative and widely used alternative to bone marrow transplantation in treatment of patients with early chronic myeloid leukemia (CML). A meta-analysis was conducted to develop a reliable prognostic scoring system for estimation of survival of patients with CML treated with interferon alfa.
A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alfa. Writing Committe for the Collaborative CML prognostic factor project groups / Hasford, J; Pfirrmann, M; Hehlmann, R; Alimena, Giuliana. - In: JOURNAL OF THE NATIONAL CANCER INSTITUTE. - ISSN 0027-8874. - 90(1998), pp. 850-858. [10.1093/jnci/90.11.850]
Scheda prodotto non validato
Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo
Titolo: | A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alfa. Writing Committe for the Collaborative CML prognostic factor project groups | |
Autori: | ||
Data di pubblicazione: | 1998 | |
Rivista: | ||
Citazione: | A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alfa. Writing Committe for the Collaborative CML prognostic factor project groups / Hasford, J; Pfirrmann, M; Hehlmann, R; Alimena, Giuliana. - In: JOURNAL OF THE NATIONAL CANCER INSTITUTE. - ISSN 0027-8874. - 90(1998), pp. 850-858. [10.1093/jnci/90.11.850] | |
Handle: | http://hdl.handle.net/11573/32596 | |
Appartiene alla tipologia: | 01a Articolo in rivista |